ondansetron 0.8 MG/ML Oral Solution

What the CMS Formulary Data Shows for ondansetron 0.8 MG/ML Oral Solution

Per the CMS 2026 Part D formulary file, ondansetron 0.8 MG/ML Oral Solution (RxNorm concept RXCUI 312085, generic name ondansetron) appears on 265 distinct formulary files spanning 4,754 Medicare Part D plan offerings - 93.8% of enrollable Part D products, near-universal placement. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 2.7.

Real-world access to ondansetron 0.8 MG/ML Oral Solution depends on utilization management as much as tier placement: 86.4% of covering formularies require prior authorization. 0% require step therapy. 32.8% apply quantity limits.

Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 2,510,273 Part D beneficiaries filled ondansetron 0.8 MG/ML Oral Solution in 2023, with total plan-and-beneficiary spending of $70,045,347 and an average per-beneficiary annual cost of $27.90. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry ondansetron 0.8 MG/ML Oral Solution today.